Cathie Wood’s ARK Invest Buys Over 60,000 Shares of Teladoc
One of Cathie Wood's ARK Invest funds bought over 60,000 shares of Teladoc on August 25.
One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Wednesday. This fund bought over 60,000 shares of Teladoc Health Inc. (NYSE: TDOC), as the price of this ETF gained slightly on Wednesday. Note that this fund is up handily in the past year.
ARK Fintech Innovation ETF (NYSEARCA: ARKF) purchased 61,374 shares of Teladoc. At Wednesday’s closing price, this would have valued the purchase at roughly $8.9 million. Even though this is a small fraction of the total holdings, every little bit counts. The ETF is up about 36% in the past 52 weeks.
Check out all of the ARK Invest buys for Wednesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | TCEHY | TENCENT | 234,835 |
| ARKF | Z | ZILLOW | 493 |
| ARKF | TDOC | TELADOC HEALTH | 61,374 |
| ARKF | COIN | COINBASE GLOBAL | 60,901 |
| ARKF | JD | JD.COM | 58,946 |
| ARKF | PDD | PINDUODUO | 75,593 |
| ARKG | PSNL | PERSONALIS | 43,612 |
| ARKG | PFE | PFIZER | 170,809 |
| ARKG | MASS | 908 DEVICES | 11,300 |
| ARKG | DYNS | DYNAMICS SPECIAL PURPOSE | 3 |
| ARKG | CMIIU | CM LIFE SCIENCES II | 18,100 |
| ARKG | ADPT | ADAPTIVE BIOTECHNOLOGIES | 30,596 |
| ARKG | QSI | QUANTUM-SI | 117,584 |
| ARKK | FATE | FATE THERAPEUTICS | 1,000 |
| ARKK | NVTA | INVITAE | 113,774 |
| ARKK | SGFY | SIGNIFY HEALTH | 206,099 |
| ARKQ | MKFG | MARKFORGED | 183,121 |
| ARKQ | KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS | 9,060 |
| ARKQ | KMTUY | KOMATSU | 96,487 |
| ARKQ | DDD | 3D SYSTEMS | 64,660 |
| ARKQ | AVAV | AEROVIRONMENT | 3,059 |
| ARKW | LPSN | LIVEPERSON | 4,423 |
| ARKW | GENI | GENIUS SPORTS | 190,893 |
| ARKX | ACIC | ATLAS CREST INVESTMENT | 121,997 |
| ARKX | MKFG | MARKFORGED | 199,884 |
| ARKX | PRNT | 3D PRINTING ETF | 12,220 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=941421][wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.
